Shares of alcohol beverage maker Constellation Brands, Inc. STZ have lost 7 percent year-to-date and the steep discount versus its peers makes it Jefferies' top large-cap growth idea.
The Analyst
Kevin Grundy maintains a Buy rating on Constellation Brands with an unchanged $283 price target.
The Thesis
Constellation Brands is scheduled to report its second-quarter results Thursday morning, which Grundy said should come in ahead of expectations. The company likely benefited from favorable summer weather and product innovation. Third-party sales trends from Nielsen suggests a 13.5-percent growth in the beer business, which accounts for around 70 percent of total profit.
Constellation is expected to report Q2 earnings of $2.60 per share on sales of $2.25 billion.
Investors can expect to see a downward revision to management's $9.40 to $9.70 EPS guidance for the full year due to the $4 billion investment in Canopy Growth Corp CGC, Grundy said in a note. A reasonable guide down to a new range of $9.10-$9.40 is justified due to near-term dilution and any accretion from the deal isn't expected until fiscal 2021.
The stock's weakness since the start of the year implies shares are trading at 15 times NTM EV/EBITDA (excluding the Canopy portion of the business), which is a discount to the 17 to 18 times recent average and its peers who trade at around 21 to 22 times.
As such, the stock is a top large-cap growth idea based on expectations for continued growth in beer through at least 2021, exposure to the new cannabis market and an attractive valuation.
Price Action
Constellation Brands was trading flat Wednesday around $212.28 per share.
Related Links:
Constellation Brands Is Overvalued, Susquehanna Says In Downgrade
Stifel's 5-Year Bullish Stance On Constellation Brands Fizzles
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
